Interferon-γ induces C/EBPβ expression and activity through MEK/ERK and p38 in T84 colon epithelial cells

American Journal of Physiology - Cell Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Salmenperä, Pertteli ^a   Hämäläinen, Sammy ^a   Hukkanen, Mika ^b   Kankuri, Esko ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

CCAAT enhancer binding protein ; Colon epithelial cells, interferon ; Interleukin 6; Mitogen activated protein kinases

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CCAAT ENHANCER BINDING PROTEIN; CYCLOHEXIMIDE; GAMMA INTERFERON; GENISTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SYNAPTOPHYSIN; SYNAPTOPHYSIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL SECRETION; COLON MUCOSA; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

EID: 0344837774     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00293.2002     Document Type: Article

References (49)

1. Adams RB, Planchon SM, and Roche JK. IFN-γ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 150: 2356-2363, 1993.
2. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, and Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9: 1897-1906, 1990.
3. Amrani Y, Ammit AJ, and Panettieri RA Jr. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-α-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogenactivated protein kinases. Mol Pharmacol 60: 646-655, 2001.
4. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, and Neurath MF. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 6: 583-588, 2000.
5. Boehm U, Klamp T, Groot M, and Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 15: 749-795, 1997.
6. Cardinaux JR, Allaman I, and Magistretti PJ. Pro-inflammatory cytokines induce the transcription factors C/EBPβ and C/EBPδ in astrocytes. Glia 29: 91-97, 2000.
7. Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, Sekikawa K, Terada N, Nakanishi K, and Okamura H. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner. Gut 47: 779-786, 2000.
8. Colgan SP, Parkos CA, Matthews JB, D'Andrea L, Awtrey CS, Lichtman AH, Delp-Archer C, and Madara JL. Interferon-γ induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am J Physiol Cell Physiol 267: C402-C410, 1994.
9. Fong TA and Mosmann TR. Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines. J Immunol 144: 1744-1752, 1990.
10. Hayashi R, Yamashita N, Matsui S, Fujita T, Araya J, Sassa K, Arai N, Yoshida Y, Kashii T, Maruyama M, Sugiyama E, and Kobayashi M. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J 16: 452-458, 2000.
11. Hershko DD, Robb BW, Luo G, and Hasselgren PO. Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 283: R1140-R1148, 2002.
12. Hogaboam CM, Vallance BA, Kumar A, Addison CL, Graham FL, Gauldie J, and Collins SM. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest 100: 2766-2776, 1997.
13. Holma R, Salmenpera P, Riutta A, Virtanen I, Korpela R, and Vapaatalo H. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur J Pharmacol 19: 309-318, 2001.
14. Holtkamp W, Stollberg T, and Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol 20: 123-126, 1995.
15. Hu J, Roy SK, Shapiro PS, Rodig SR, Reddy SP, Platanias LC, Schreiber RD, and Kalvakolanu DV. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-β-dependent gene transcription in response to interferon-γ. J Biol Chem 276: 287-297, 2001.
16. Huang GT, Eckmann L, Savidge TC, and Kagnoff MF. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil adhesion. J Clin Invest 98: 572-583, 1996.
17. Hungness ES, Robb BW, Luo GJ, Hershko DD, and Hasselgren PO. Hyperthermia-induced heat shock activates the transcription factor c/EBP-β and augments IL-6 production in human intestinal epithelial cells. J Am Coll Surg 195: 619-626, 2002.
18. Iwata M, Suzuki Y, Imai Y, Ono Y, and Sawa M. Differential effects of protein tyrosine kinase inhibitors on interferon-γ-induction of major histocompatibility complex class II and intercellular adhesion molecule-1 expression in human corneal epithelial cells. Jpn J Ophthalmol 45: 13-21, 2001.
19. Jaffee BD, Manos EJ, Collins RJ, Czerniak PM, Favata MF, Magolda RL, Scherle PA, and Trzaskos JM. Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo. Biochem Biophys Res Commun 268: 647-651, 2000.
20. Kaiserlian D, Rigal D, Abello J, and Revillard JP. Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol 21: 2415-2421, 1991.
21. Kansra SV, Reddy MA, Weng YI, and Shukla SD. Activation of mitogen activated protein kinase in human platelets by genistein. Pharmacol Res 39: 21-31, 1999.
22. Kisseleva T, Bhattacharya S, Braunstein J, and Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 20: 1-24, 2002.
23. Kolios G, Brown Z, Robson RL, Robertson DA, and Westwick J. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol 116: 2866-2872, 1995.
24. Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta J, Kuroiwa A, Ina K, Kanayama K, Ando T, and Matsuura T. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig Dis Sci 40: 949-959, 1995.
25. Kyriakis JM and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001.
26. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, and Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47: 185-201, 2000.
27. Lin WW and Hsu YW. Cycloheximide-induced cPLA(2) activation is via the MKP-1 down-regulation and ERK activation. Cell Signal 12: 457-461, 2000.
28. Lowry OH, Rosenbrough NJ, Farr AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
29. MacDonald TT, Hutchings P, Choy MY, Murch S, and Cooke A. Tumour necrosis factor-alpha and interferon-γ production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81: 301-305, 1990.
30. Papanicolaou DA, Wilder RL, Manolagas SC, and Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127-137, 1998.
31. Parikh AA, Salzman AL, Fischer JE, Szabo C, and Hasselgren PO. Interleukin-1 β and interferon-γ regulate interleukin-6 production in cultured human intestinal epithelial cells. Shock 8: 249-255, 1997.
32. Parkos CA, Colgan SP, Diamond MS, Nusrat A, Liang TW, Springer TA, and Madara JL. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils. Mol Med 2: 489-505, 1996.
33. Raab Y, Hallgren R, and Gerdin B. Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis. Digestion 55: 44-49, 1994.
34. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, and Stark GR. Stat1-independent regulation of gene expression in response to IFN-γ. Proc Natl Acad Sci USA 98: 6674-6679, 2001.
35. Ramji DP and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575, 2002.
36. Reinisch W, Gasche C, Tillinger W, Wyatt J, Lichtenberger C, Willheim M, Dejaco C, Waldhor T, Bakos S, Vogelsang H, Gangl A, and Lochs H. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol 94: 2156-2164, 1999.
37. Robb BW, Hershko DD, Paxton JH, Luo GJ, and Hasselgren PO. Interleukin-10 activates the transcription factor C/EBP and the interleukin-6 gene promoter in human intestinal epithelial cells. Surgery 132: 226-231, 2002.
38. Rogler G and Andus T. Cytokines in inflammatory bowel disease. World J Surg 22: 382-389, 1998.
39. Roy SK, Hu J, Meng Q, Xia Y, Shapiro PS, Reddy SP, Platanias LC, Lindner DJ, Johnson PF, Pritchard C, Pages G, Pouyssegur J, and Kalvakolanu DV. MEKK1 plays a critical role in activating the transcription factor C/EBP-βdependent gene expression in response to IFN-γ. Proc Natl Acad Sci USA 99: 7945-7950, 2002.
40. Roy SK, Wachira SJ, Weihua X, Hu J, and Kalvakolanu DV. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J Biol Chem 275: 12626-12632, 2000.
41. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, and Ogawa S. ERK and p38 MAPK, but not NF-κB, are critically involved in reactive oxygen speciesmediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89: 661-669, 2001.
42. Shanahan F. Crohn's disease. Lancet 359: 62-69, 2002.
43. Shao L, Serrano D, and Mayer L. The role of epithelial cells in immune regulation in the gut. Semin Immunol 13: 163-176, 2001.
44. Siavoshian S, Blottiere HM, Bentouimou N, Cherbut C, and Galmiche JP. Butyrate enhances major histocompatibility complex class I, HLA-DR and ICAM-1 antigen expression on differentiated human intestinal epithelial cells. Eur J Clin Invest 26: 803-810, 1996.
45. Sollid LM, Gaudernack G, Markussen G, Kvale D, Brandtzaeg P, and Thorsby E. Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol 25: 175-180, 1987.
46. ten Hove T, van den Blink B, Pronk I, Drillenburg P, Peppelenbosch MP, and van Deventer SJ. Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut 50: 507-512, 2002.
47. Van Kemseke C, Belaiche J, and Louis E. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis 15: 206-210, 2000.
48. Weihua X, Kolla V, and Kalvakolanu DV. Interferon γ-induced transcription of the murine ISGF3γ (p48) gene is mediated by novel factors. Proc Natl Acad Sci USA 94: 103-108, 1997.
49. Yamamoto M, Yoshizaki K, Kishimoto T, and Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164: 4878-4882, 2000.